What check size does Kelly Qiao write?

Kelly Qiao typically writes checks of $25M – $60M.

Where did Kelly Qiao go to school?

Kelly Qiao studied at The Chinese University of Hong Kong (Master of Business Administration - MBA, Finance); Tsinghua University (PhD, Biology); Tsinghua University (Bachelor's degree, Chemistry).

Kelly Qiao

Former Senior Principal at B Capital Group · Former Managing Director at Fosun International

China

Writes $25M – $60M checks · typically $25M

Find your path to Kelly

481 people in our graph can introduce you to Kelly.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Garri Zmudze to introduce you to Kelly

You →Garri · together at Insilico Medicine (2021–2026) →Kelly

Ask Jamie Chen to introduce you to Kelly

You →Jamie · together at Insilico Medicine →Kelly

Ask Sam Okafor to introduce you to Kelly

You →Sam · 10 people · together at B Capital →Kelly

Your email: the people you already email who know Kelly
2nd- and 3rd-degree connections: people you know who worked, studied or invested with Kelly
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

About

Kelly Qiao is the Asia Healthcare lead at B Capital and an investor and observer at Rona Therapeutics. With over 15 years of experience in R&D, sales, marketing, and healthcare investment, Qiao has led investments in multiple companies including Profoundbio (which completed a $1.8B acquisition in 2024), Insilico Medicine, CR Phoenix, and ChipScreen, among others. Qiao holds an FMBA from The Chinese University of Hong Kong and a PhD in biology from Tsinghua University, and has worked at GlaxoSmithKline, Roche, Temasek Vertex, Fosun Capital, and Tuspark Venture.

Experience

Rona TherapeuticsInvestor and Observercurrent2025 — present
Vivacta BiotechnologyInvestor and Observercurrent2025 — present
MacroLux Medical Technology Co., Ltd.Investor and Observercurrent2024 — present
Spectrumedics InternationalInvestor and Boardcurrent2024 — present
Grit BiotechnologyInvestor and Observercurrent2023 — present
AlphaLife SciencesInvestor and Observercurrent2022 — presentChina
ProfoundBioInvestor and Observercurrent2022 — present
Beijing Yuanxin Technology Co., Ltd.Investorcurrent2021 — present
镁信健康Investorcurrent2021 — presentChina
Insilico MedicineInvestor and Observercurrent2021 — present
B CapitalSenior Principalcurrent2021 — present
Taikang Insurance Group Inc.Managing Director2018 — 2020
Fosun GroupManaging Director2016 — 2018
Phoenix Healthcare Group Co LtdInvestor2013 — 2015
Vertex VenturesExecutive Director2012 — 2015Beijing
Shenzhen Chipscreen Biosciences Co., Ltd.Investor and Board Member2013 — 2015
Roche DiagnosticsSupervisor2010 — 2012Beijing
GlaxoSmithKlineResearch Scientist2009 — 2010

Skills & more

Life Sciences14Biotechnology28Genetics16Clinical7Drug Discovery35Oncology30Pharmaceuticals7Diagnostics6Venture Capital15Investments11Infectious Diseases13Clinical Trials14

+12 more

Clinical DevelopmentHealthcareSequencingDue DiligenceMolecular BiologyGenomicsImmunologyLifesciencesBiopharmaceuticalsClinical ResearchCancerHardware Diagnostics

Languages English · Mandarin

From Kelly's professional profile.

Frequently asked questions

Who is Kelly Qiao?: Kelly Qiao is the Asia Healthcare lead at B Capital and an investor and observer at Rona Therapeutics. With over 15 years of experience in R&D, sales, marketing, and healthcare investment, Qiao has led investments in multiple companies including Profoundbio (which completed a $1.8B acquisition in 2024), Insilico Medicine, CR Phoenix, and ChipScreen, among others. Qiao holds an FMBA from The Chinese University of Hong Kong and a PhD in biology from Tsinghua University, and has worked at GlaxoSmithKline, Roche, Temasek Vertex, Fosun Capital, and Tuspark Venture.
What check size does Kelly Qiao write?: Kelly Qiao typically writes checks of $25M – $60M.
Where did Kelly Qiao go to school?: Kelly Qiao studied at The Chinese University of Hong Kong (Master of Business Administration - MBA, Finance); Tsinghua University (PhD, Biology); Tsinghua University (Bachelor's degree, Chemistry).